Biosimilar Monoclonal Antibody Market
This market involves biosimilar versions of monoclonal antibody drugs used to treat various diseases, including cancer and autoimmune disorders. These alternatives offer cost-effective treatment options. Growth is driven by patent expirations of biologics and increasing demand for affordable healthcare.